Next Article in Journal
Comparison of Four Systems for SARS-CoV-2 Antibody at Three Time Points after SARS-CoV-2 Vaccination
Next Article in Special Issue
Alignment of the Cervix with the Vagina in Uterine Retroversion: A Possible Risk Factor in Uterine Prolapse
Previous Article in Journal
Detecting Abnormal Axillary Lymph Nodes on Mammograms Using a Deep Convolutional Neural Network
Previous Article in Special Issue
Cervical Power Doppler Angiography with Micro Vessel Blood Flow Indices in the Auxiliary Diagnosis of Acute Cervicitis
 
 
Review
Peer-Review Record

Ultrasound-Guided Trans-Uterine Cavity Core Needle Biopsy of Uterine Myometrial Tumors to Differentiate Sarcoma from a Benign Lesion—Description of the Method and Review of the Literature

Diagnostics 2022, 12(6), 1348; https://doi.org/10.3390/diagnostics12061348
by Maciej Stukan 1,2,*, Piotr Rutkowski 3, Jeremy Smadja 4 and Sylvie Bonvalot 5
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Diagnostics 2022, 12(6), 1348; https://doi.org/10.3390/diagnostics12061348
Submission received: 29 March 2022 / Revised: 23 May 2022 / Accepted: 23 May 2022 / Published: 29 May 2022
(This article belongs to the Special Issue Imaging of Gynecological Disease)

Round 1

Reviewer 1 Report

I read your manuscript with great interest and agree with your conclusion that ultrasound-guided trans-uterine cavity (UG-TUC) core needle biopsy would certainly be beneficial to the patients who turns out to have uterine sarcomas.  However, as you pointed out in your manuscript, it needs to be utilized in select patient population where the imaging findings raise the possibility of uterine sarcoma.  

Author Response

Dear Reviewer,

 

Thank you very much for your opinion and valuable comment on our article. We very much appreciate your experience in the field, and that you had time and took the effort to review the manuscript.

 

Thank you for pointing out the issue that the UG-TUC core needle biopsy can be utilized in a selected patient population (not all), where the imaging findings raise the possibility of uterine sarcoma. It is expressed in the conclusions section.

The expert ultrasonography assessment of uterine lesions is the first-line and most often the only needed diagnostic tool to plan clinical management. However, atypical lesions are to be expected, and then the core needle biopsy should be considered.

After the review, we added Appendix A, where we presented the case series with the application of the core needle biopsy as an additional tool to ultrasonography. Most of the myometrium lesions were considered atypical in ultrasound. In some cases, the core needle biopsy results helped to make the optimal decision about clinical management.

 

Yours sincerely,

 

in the name of all authors,

Maciej Stukan

Reviewer 2 Report

The article presents an interesting line of work with the contribution of diagnostic information in the search for pathological cases that can penalize the prognosis of patients. The authors' proposal is good and the reflection in the use of a new device seems correct to us.
However, every mechanism or instrument in its clinical application must be supported by its results. The article details the cases in which it should be used and the mechanism of operation and use of it. But it would reinforce and validate its use if the authors, even if they were, presented some of their results. The design can be very successful but it must be backed by a clear utility and this is inexorably backed by the results, complication rate, false negatives, etc.

Author Response

Dear Reviewer,

 

Thank you very much for your opinion and valuable comments on our article. We very much appreciate your experience in the field, and that you had time and took the effort to review the manuscript.

 

Thank you for pointing out the issue that the clinical application of the UG-TUC core needle biopsy must be supported by its results. We acknowledge this and expressed it at the end of the manuscript (lines 333-338, the revised version), where we discuss limitations of the our project. Also, we addressed this issue in the conclusions section (lines 354-358, the revised version). Given the rarity of uterine sarcomas, the research on the feasibility, accuracy, and safety of the UG-TUC core needle biopsy should be carried out by many clinicians in an international network for rare tumors.

 

Encouraged by your suggestion (“the authors, …, presented some of their results”) we added the Appendix A, where we presented the case series with the application of the core needle biopsy as an additional tool to ultrasonography. Most of the myometrium lesions were considered atypical in ultrasound. In some cases, the core needle biopsy results helped to make the optimal decision about clinical management.

 

We consider Appendix A as an added value to the manuscript, thank you for the suggestion, and hope you will accept our response.

 

Yours sincerely,

 

in the name of all authors,

Maciej Stukan

Reviewer 3 Report

This review paper, entitled Ultrasound-guided trans-uterine cavity core needle biopsy of uterine myometrial tumors to differentiate sarcoma from a benign lesion – description of the method and review of the literature, was very excellent in describing advantages, disadvantages and complications. The authors also showed the method detailed using the video. It is helpful in clinical practice. I suggest accept in present form.

Author Response

Dear Reviewer,

 

Thank you very much for your opinion on our article. We very much appreciate your experience in the field, and that you had time and took the effort to review the manuscript.

 

We thank you for your acclaim of the manuscript in the presented form. We are very happy about it.

 

 

Yours sincerely,

 

in the name of all authors,

Maciej Stukan

Back to TopTop